支持戒除抗抑郁药物的资源的可接受性和优化:一项与澳大利亚初级保健患者进行的定性大声思考研究
Suzanne McDonald1, Katharine Wallis1, Mark Horowitz2
1General Practice Clinical Unit, Medical School, University of Queensland, Brisbane, Australia.
概括
由于戒断,停止长期使用抗抑郁药是具有挑战性的. 新的RELEASE资源被认为是可以接受的,对患者和医生在抗抑郁药物停用过程中有用.
科学领域:
- 精神病学是一个精神病学.
- 患者教育 患者教育
- 基于证据的医学基于证据的医学.
背景情况:
- 由于戒断症状,停止长期服用抗抑郁药物可能很困难.
- 患者往往缺乏识别和管理这些戒断症状的知识.
- 减少长期使用抗抑郁药物 (RELEASE) 的资源是为了弥补这些差距而开发的.
研究的目的:
- 探索患者接受RELEASE资源的可能性.
- 优化RELEASE资源的使用和影响.
主要方法:
- 在长期使用抗抑郁药的成年人中进行了一项大声思考的采访研究.
- 参与者 (n=14) 来自澳大利亚昆士兰州东南部的一般诊所.
- 采访被反复分析以修改资源.
主要成果:
- 参与者发现RELEASE资源是相关的,信息丰富的,激励性的和可用的.
- 患者反导致了措辞,内容顺序和布局的修改.
- 参与者表达了强烈的需要,这些资源是广泛可访问的.
结论:
- 释放资源被认为是可以接受的,有用的,并可能改变患者停止服用抗抑郁药的生命.
- 该研究强调了以患者为中心的资源在管理抗抑郁药物戒断中的重要性.
- 进一步的研究正在评估这些资源在一般实践环境中的有效性.
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
234
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
234
01:25Antidepressant Drugs: Overview
490
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
490
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
394
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
394
01:28Drug Therapy
44
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
44
01:26Psychosis: Goals of Pharmacotherapy
131
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
131
01:30Electroconvulsive Therapy
41
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
41